Skip to main content

Table 6 Quality of life

From: Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis

 

Standardized physical component Mean (SD)

Standardized mental component Mean (SD)

p-value

Seizures

   

 No (N = 17)

50.11 (8.79)

47.59 (7.14)

PC:0.054

 Yes, controlled, no seizures in 1 year (N = 23)

48.38 (8.29)

44.12 (8.16)

 

 Yes, controlled, seizures in last year (N = 4)

42.83 (10.16)

50.05 (7.91)

MC:0.264

 Uncontrolled (N = 5)

37.52 (14.61)

42.15 (9.23)

 

TAND

   

 No (N = 26)

49.39 (8.55)

47.21(6.47)

PC: 0.002

 Mild (N = 13)

50.75 (6.44)

42.49 (10.31)

 

 Moderate (N = 5)

41.96 (8.64)

49.94 (4.56)

MC: 0.104

 Severe (N = 5)

33.98 (13.33)

41.08 (8.17)

 

Cortical dysplasia

   

 No (N = 6)

50.85 (6.92)

47.40 (6.21)

PC: 0.211

 Yes (N = 43)

46.94 (10.13)

45.36(8.24)

MC: 0.378

 No (N = 22)

46.86 (9.76)

44.09 (8.43)

PC: 0.994

Subependymal nodule

   

 Yes (N = 27)

47.88 (10.04)

46.85 (7.54)

MC: 0.628

Astrocytoma

   

 No (N = 34)

48.73 (8.04)

45.44 (8.71)

PC: 0.008

 Yes (N = 15)

44.46 (12.84)

45.99 (6.32)

MC: 0.198

AML

   

 None (N = 16)

50.41(7.60)

47.37 (7.57)

PC: 0.461

 Single (N = 2)

49.12 (7.72)

46.48 (5.41)

 

 Several (N = 5)

46.16 (4.33)

47.74 (6.66)

MC: 0.555

 Multiple > 3 (N = 26)

47.42 (11.62)

44.05 (8.63)

 

LAM

   

 No (N = 34)

47.74 (10.02)

45.58 (7.64)

PC: 0.851

 Mild (N = 10)

48.08 (9.47)

47.09 (4.96)

 

 Moderate (N = 4)

44.77 (11.96)

46.59 (13.84)

MC: 0.145

 Severe (N = 1)

40.76

27.81

 

Skin

   

 No (N = 8)

52.61 (7.73)

48.62 (6.52)

PC: 0.297

 Yes (N = 41)

46.41 (9.95)

45.02 (8.18)

MC: 0.536

Rhabdomyoma

   

 No (N = 33)

48.00 (9.90)

45.91 (7.53)

PC: 0.739

 Yes ( N = 16)

46.24 (9.87)

45.00 (9.09)

MC: 0.208

Retinal hamartoma

   

 No (N = 40)

46.99 (10.39)

45.16 (8.63)

PC: 0.241

 Yes (N = 9)

49.36 (6.89)

47.61 (3.81)

MC: 0.023

Diagnosis

   

 Childhood (N = 27)

47.2 (10.1)

43.46 (9.04)

PC: 0.519

 Adult (N = 20)

48.04 (9.55)

48.25 (5.47)

MC:0.023

  1. Bold highlights statistically significant results
  2. TAND, TSC-associated neuropsychiatric disorders; AML, angiomyolipoma; LAM, lymphangioleiomyomatosis; SD, standard deviation; PC, physical component; MC, mental component